feed,title,long_url,short_url
RS,"Safety and pharmacodynamics of intranasal administration of recombinant human interferon alfa-2b as a potential prophylactic for SARS-CoV-2 infection in an at-risk group: a phase I-II clinical trial, open, uncontrolled, in a single-arm (OLIVO Study)",https://www.researchsquare.com/article/rs-5271166/latest,https://da.gd/qcNuH7
